Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study.

Front Oncol · 2013 · PMC3740480 · PMID 23964347

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

BRCA polymorphism ovarian cancer chemotherapy prognosis BRCA2 N372H polymorphism ( N = 228) All six AA women exhibited the CC genotype in BRCA2 N372H (Table 2 ) but the relationship between the N372H polymorphism and race did not reach statistical significance in this study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.